Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 142,531 |
|
|||||
| News | (2) |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Silexion Therapeutics Corporation | SLXNW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0124 | 34.83% | 0.048 | 12:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.044 | 0.036 | 0.055 | 0.0478 | 0.0356 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 73 | 142,531 | 0.0528686 | 7,535 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:33:23 | formt | 110 | 0.048 | USD |
Silexion Therapeutics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 76.95k | - | - | - | 0.16 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Silexion Therapeutics
| Date | Time | Source | Heading |
|---|---|---|---|
| 17/1/2025 | 22:56 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17/1/2025 | 22:44 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 16/1/2025 | 16:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 16/1/2025 | 08:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15/1/2025 | 22:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15/1/2025 | 09:02 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 14/1/2025 | 22:19 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 14/1/2025 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 18/12/2024 | 22:00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 17/12/2024 | 23:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/12/2024 | 01:42 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 11/12/2024 | 01:41 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
SLXNW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
NASDAQ:SLXNW -
What is the current Silexion Therapeutics Corporation share price?
The current share price of Silexion Therapeutics Corporation is US$ 0.048
What is the 1 year trading range for Silexion Therapeutics Corporation share price?
Silexion Therapeutics Corporation has traded in the range of US$ 0.00 to US$ 0.00 during the past year
